Invention Grant
- Patent Title: Pteridinone derivatives as PI3-kinases inhibitors
- Patent Title (中): 蝶啶酮衍生物作为PI3-激酶抑制剂
-
Application No.: US12524791Application Date: 2008-01-28
-
Publication No.: US08410100B2Publication Date: 2013-04-02
- Inventor: Riccardo Giovannini , Sara Frattini , Trixi Brandl , Steffen Breitfelder , Enzo Cereda , Matthias Grauert , Matthias Hoffman , Anne T. Joergensen , Udo Maier , Alexander Pautsch , Monica Quai , Stefan Scheuerer
- Applicant: Riccardo Giovannini , Sara Frattini , Trixi Brandl , Steffen Breitfelder , Enzo Cereda , Matthias Grauert , Matthias Hoffman , Anne T. Joergensen , Udo Maier , Alexander Pautsch , Monica Quai , Stefan Scheuerer
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: EP07101544 20070201
- International Application: PCT/EP2008/050986 WO 20080128
- International Announcement: WO2008/092831 WO 20080807
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K31/525
Abstract:
New compounds of Formula (1) are provided which by virtue of their pharmaceutical activity as PI3-kinase modulators may be used in the therapeutic field for the treatment of inflammatory or allergic diseases. Examples of these include inflammatory and allergic respiratory complaints, inflammatory diseases of the gastro-intestinal tract and motor apparatus, inflammatory and allergic skin diseases, inflammatory eye diseases, diseases of the nasal mucosa, inflammatory or allergic conditions involving autoimmune reactions or inflammations of the kidney.
Public/Granted literature
- US20100099680A1 PTERIDINONE DERIVATIVES AS P13-KINASES INHIBITORS Public/Granted day:2010-04-22
Information query
